NautaDutilh and Goodwin Procter LLP advised Xenikos on the deal. Xenikos B.V., a clinical-stage biopharmaceutical company currently developing a novel therapy for treating immune related disorders,...
This content is for Standard 1 Year members only. LoginJoin Now